These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 9032322

  • 1. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
    Miller CJ, McChesney MB, Lü X, Dailey PJ, Chutkowski C, Lu D, Brosio P, Roberts B, Lu Y.
    J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
    [Abstract] [Full Text] [Related]

  • 2. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.
    Miller CJ, Marthas M, Greenier J, Lu D, Dailey PJ, Lu Y.
    J Virol; 1998 Apr; 72(4):3248-58. PubMed ID: 9525652
    [Abstract] [Full Text] [Related]

  • 3. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
    Lü X, Kiyono H, Lu D, Kawabata S, Torten J, Srinivasan S, Dailey PJ, McGhee JR, Lehner T, Miller CJ.
    AIDS; 1998 Jan 01; 12(1):1-10. PubMed ID: 9456249
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of a SHIV 89.6 proviral DNA vaccine against mucosal SIVmac239 challenge.
    Busch M, Abel K, Li J, Piatak M, Lifson JD, Miller CJ.
    Vaccine; 2005 Jul 01; 23(31):4036-47. PubMed ID: 15963361
    [Abstract] [Full Text] [Related]

  • 5. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
    McChesney MB, Collins JR, Lu D, Lu X, Torten J, Ashley RL, Cloyd MW, Miller CJ.
    J Virol; 1998 Dec 01; 72(12):10029-35. PubMed ID: 9811741
    [Abstract] [Full Text] [Related]

  • 6. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
    Kumar A, Mukherjee S, Shen J, Buch S, Li Z, Adany I, Liu Z, Zhuge W, Piatak M, Lifson J, McClure H, Narayan O.
    Virology; 2002 Sep 30; 301(2):189-205. PubMed ID: 12359422
    [Abstract] [Full Text] [Related]

  • 7. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS, Hurtrel B, Beyer C, Gloeckler L, Ledger TN, Moog C, Kieny MP, Mehtali M, Schmitt D, Gut JP, Kirn A, Aubertin AM.
    AIDS Res Hum Retroviruses; 1997 Jul 20; 13(11):913-22. PubMed ID: 9223407
    [Abstract] [Full Text] [Related]

  • 8. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A, Akagi T, Enose Y, Ueno M, Kawamura M, Horiuchi R, Hiraishi K, Adachi M, Serizawa T, Narayan O, Akashi M, Baba M, Hayami M.
    J Med Virol; 2004 Jul 20; 73(3):368-77. PubMed ID: 15170630
    [Abstract] [Full Text] [Related]

  • 9. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG, Soundaramourty C, Benferhat R, Le Grand R, Dereuddre-Bosquet N, Krust B, Estaquier J.
    J Virol; 2018 Sep 15; 92(18):. PubMed ID: 29976675
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
    Abel K, Compton L, Rourke T, Montefiori D, Lu D, Rothaeusler K, Fritts L, Bost K, Miller CJ.
    J Virol; 2003 Mar 15; 77(5):3099-118. PubMed ID: 12584336
    [Abstract] [Full Text] [Related]

  • 12. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.
    Buge SL, Murty L, Arora K, Kalyanaraman VS, Markham PD, Richardson ES, Aldrich K, Patterson LJ, Miller CJ, Cheng SM, Robert-Guroff M.
    J Virol; 1999 Sep 15; 73(9):7430-40. PubMed ID: 10438833
    [Abstract] [Full Text] [Related]

  • 13. Utility of SHIV for testing HIV-1 vaccine candidates in macaques.
    Lu Y, Salvato MS, Pauza CD, Li J, Sodroski J, Manson K, Wyand M, Letvin N, Jenkins S, Touzjian N, Chutkowski C, Kushner N, LeFaile M, Payne LG, Roberts B.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun 01; 12(2):99-106. PubMed ID: 8680896
    [Abstract] [Full Text] [Related]

  • 14. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
    Song B, Cayabyab M, Phan N, Wang L, Axthelm MK, Letvin NL, Sodroski JG.
    Virology; 2004 Apr 25; 322(1):168-81. PubMed ID: 15063126
    [Abstract] [Full Text] [Related]

  • 15. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K, Cecilia D, Ami Y, Nakasone T, Matsuo K, Burda S, Yamamoto H, Yoshino N, Kaizu M, Ando S, Okuda K, Zolla-Pazner S, Yamazaki S, Yamamoto N, Honda M.
    J Virol; 2005 Feb 25; 79(3):1452-62. PubMed ID: 15650171
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Infection of baboons with a simian immunodeficiency virus/HIV-1 chimeric virus constructed with an HIV-1 Thai subtype E envelope.
    Klinger JM, Himathongkham S, Legg H, Luciw PA, Barnett SW.
    AIDS; 1998 May 28; 12(8):849-57. PubMed ID: 9631137
    [Abstract] [Full Text] [Related]

  • 20. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope.
    Quesada-Rolander M, Mäkitalo B, Thorstensson R, Zhang YJ, Castaños-Velez E, Biberfeld G, Putkonen P.
    AIDS Res Hum Retroviruses; 1996 Jul 20; 12(11):993-9. PubMed ID: 8827215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.